Investor Relations

SCA’s interim report for Q2 2010 – pre-tax profit 12 percent up

SCA’s interim report for Q2 2010 – pre-tax profit 12 percent up

Net sales decreased by 3% (excluding exchange rate effects, net sales increased by 4%) to SEK 54,374m (56,242). Profit before tax, excluding restructuring costs, rose 12% (16% excluding exchange rate effects) to SEK 3,944m (3,525). Earnings per share were SEK 3.57 (3.24). Cash flow from current operations was SEK 2,816m (4,687).
Baby diapers acquisition strengthens SCA´s presence in Mexico and Central America

Baby diapers acquisition strengthens SCA´s presence in Mexico and Central America

SCA is purchasing the Copamex baby diaper business in Mexico and Central America. The purchase price is equivalent to approximately USD 50m on a debt-free basis.

Our businesses

Our businesses All info about SCA's four business areas (Personal Care, Tissue, Packaging, Forest Products) in one place: brands, products, targets, strategies, market updates, operations and key figures.

Strategies & innovation

Strategies & innovation SCA's strategy builds on customer and consumer insight, regional presence with global strenght and sustainable development. Innovation is a prerequisite for many strategic actions. Read more about:

Press releases

31 Aug 2010, 11:00
Conversion of shares
30 Aug 2010, 16:29
Interim report for AB SCA Finans released
21 Jul 2010, 08:05
Baby diapers acquisition strengthens SCA´s presence in Mexico and Central America

Presentations

21 Jul 2010, 10:01
SCA Interim report Q2 2010
15 Jun 2010, 11:15
Deutsche Bank Consumer Goods conference, Paris
20 May 2010, 00:00
NASDAQ OMX and SEB Enskilda Nordic Market Day
Print Add to PDF basket View PDF basket

2010-09-03, 17:29

Share upSCA B 0.10 (0.1%) 103.00 SEK

Investor relations contacts

Johan Karlsson
Vice President, Investor Relations
Mobile: +46 70 511 15 81
Direct: +46 8 788 51 30

Jessica Ölvestad
Manager, Investor Relations
Mobile: +46 70 537 58 38
Direct: +46 8 788 52 82

Janet Flygare
Investor Relations Coordinator
Mobile: +46 70 310 13 74
Direct: +46 8 788 51 63

General investors contact